Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults

• Main Authors: Ho, Sharlene, Wong, Joshua Guoxian, Ng, Oon Tek, Lee, Cheng Chuan, Leo, Yee Sin, Lye, David Chien Boon, Wong, Chen Seong
• 其他作者: Lee Kong Chian School of Medicine (LKCMedicine)
• 格式: Article
• 語言: English
• 出版: 2021
• 主題: Science::Medicine; Abacavir; Rilpivirine
• 在線閱讀: https://hdl.handle.net/10356/148362
• 機構: Nanyang Technological University

Background: The anti-retroviral combination of abacavir/lamivudine plus rilpivirine (ABC/3TC/RPV) is not recommended by international guidelines as the first-line regimen. However, it is potent, well-tolerated, and affordable, especially in resource-limited settings. This study evaluates the efficac...